| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Feb―27 |
IN SILICO ANALYSIS OF NOVEL COMPOUNDS TARGETING THE SARS-COV-2 PAPAIN-LIKE PROTEASE |
HABEEB RAJA S., ANBUMURUGAN S. P., IRFANA K., SUSMITHA V., ARUN KESAVH S., NITHEESH A., et al. (+2) MUTHUKUMARAN M., MOHD ABDUL BAQI |
| 2 |
[GO] |
2026―Feb―27 |
THE COVID-19 CATALYST: A CRITICAL REVIEW OF ACCELERATED DRUG REPURPOSING STRATEGIES, LESSONS LEARNED, AND FUTURE DIRECTIONS |
PEDIREDDI SOBITHA RANI, PULLA UDAYA CHANDRIKA, G. SUSMITHA, LAKSHMI DEVI GOTTEMUKKULA, MOHD ABDUL HADI |
| 3 |
[GO] |
2026―Jan―19 |
INTRANASAL VACCINE BASED ON VIRUS-LIKE PARTICLES FOR COVID-19 PREVENTION: EFFECTS ON BODY WEIGHT, IMMUNOGENICITY AND EFFICACY ASSESSMENT IN HAMSTERS |
VALERIA M. KONDRATYEVA, YANA YU. CHERNORYZH, VICTOR F. LARICHEV, IRINA T. FEDYAKINA, OLESYA V. ELISEEVA, OLEG E. LATYSHEV, TATYANA V. GREBENNIKOVA |
| 4 |
[GO] |
2025―Nov―10 |
MOLECULAR AND EPIGENETIC MECHANISMS OF COVID-19-RELATED CARDIOVASCULAR COMPLICATIONS: MULTIOMICS BIOMARKERS AND PRECISION MEDICINE APPROACHES |
KETAKI DAWALE, PANKAJ JAMBHOLKAR, VASANT WAGH |
| 5 |
[GO] |
2025―Sep―16 |
DEVELOPMENT OF REDUCED GRAPHENE OXIDE (RGO) NANOSHEETS FOR ULTRASENSITIVE DETECTION OF A NOVEL CORONA VIRUS SARS-COV-2 |
DEEPAK V. SAWANT, PRANAV K. KATKAR, ARUNKUMAR PARTHASARATHY, R. K. SHARMA, SHIVAJI KASHTE, C. D. LOKHANDE |
| 6 |
[GO] |
2025―Sep―16 |
CASE-CONTROL STUDY OF IMMUNOGLOBULINES AND PANCREATIC ENZYME ALTERATIONS IN COVID-19 IRAQI PATIENTS |
ZAHRAA MOHAMMED ALI NAJI, LUBNA A. ALZUBAIDI, IHAB I. AL KHALIFA, SHAIMAA M. MOHAMMED |
| 7 |
[GO] |
2025―Sep―16 |
FORMULATION AND EVALUATION OF DRY POWDER INHALABLE NANOPARTICLES FOR THE TREATMENT OF COVID-19 |
SAGAR VS, JANAKIRAMAN K., JOYSA RUBY J. |
| 8 |
[GO] |
2025―Mar―17 |
PRODUCTION OF POTENT NEUTRALIZING POLYCLONAL ANTIBODIES AGAINST SEVERE ACUTE RESPIRATORY SYNDROME-CORONAVIRUS-2 (SARS-CoV-2) IN RABBITS, IMMUNIZED WITH RECEPTOR BINDING DOMAIN HEPATITIS B SURFACE ANTIGEN CONJUGATE PROTEIN AND WHOLE INACTIVATED SARS-CoV-2 (MT416726): A COMPARATIVE STUDY |
DHAIRYASHEEL YADAV, NANDKUMAR KADAM, S. MOHAN KARUPPAYIL, MAYUR VIKHARANKAR, UMESH SHALIGRAM, ASHWINI K. JADHAV |
| 9 |
[GO] |
2025―Mar―17 |
COMPUTATIONAL MULTI-FACTOR MODELING TO THE SIMULTANEOUS DETERMINATION OF ASSAY AND RELATED SUBSTANCES METHOD DEVELOPMENT, VALIDATION, AND IDENTIFICATION OF MAJOR DEGRADATION PRODUCT OF COVID-19 DRUG MOLNUPIRAVIR BY HPLC: A STRATEGIC RESEARCH USING AQBD |
SANDIP KUMAR DEY, SUMANTA MONDAL |
| 10 |
[GO] |
2024―Oct―17 |
LITERATURE REVIEW: THE OMICS STUDY FOR DETERMINING BIOMARKERS IN HUMAN SERUM AND PLASMA WITH DIFFERENT COVID-19 SEVERITY |
WAHYU UTAMI, NAUFAL FARRAS |
| 11 |
[GO] |
2024―Oct―17 |
KNOWLEDGE, ATTITUDE, AND PRACTICE TOWARD COVID-19: COMMUNITY-BASED CROSS-SECTIONAL STUDY |
TRI YULIANTI, HIDAYAH KARUNIAWATI, NURUL MUTMAINAH, LISTIANA MASYITA DEWI, AISYAH SHABRINA ADANI, TITIK SUSILOWATI |
| 12 |
[GO] |
2024―Sep―11 |
LEVERAGING THE SUCCESS OF MRNA LIPID NANOPARTICLE VACCINE IN COVID-19 TREATMENT: A NARRATIVE REVIEW ON ITS POTENTIAL APPLICATION IN MALARIA TREATMENT |
FRANKLYN NONSO IHEAGWAM, ENIOLA DEBORAH ADEDOYIN |
| 13 |
[GO] |
2024―Jul―11 |
A COMPREHENSIVE REVIEW ON THE MULTIFACETED INTERACTIONS BETWEEN HOST IMMUNITY AND VIRAL PATHOGENESIS IN COVID-19 |
MAIREMBAM STELIN SINGH, SAILU YELLABOINA, MAIRAJ AHMED ANSARI |
| 14 |
[GO] |
2024―Mar―11 |
DECODING THE THERAPEUTIC POTENTIAL OF EMPON-EMPON: A BIOINFORMATICS EXPEDITION UNRAVELING MECHANISMS AGAINST COVID-19 AND ATHEROSCLEROSIS |
NUR HASANAH, FADLINA CHANY SAPUTRI, ALHADI BUSTAMAM, VANNAJAN SANGHIRAN LEE, ARRY YANUAR |
| 15 |
[GO] |
2024―Mar―11 |
ANTIVIRAL ACTIVITY OF SAUSSUREA LAPPA ETHANOL EXTRACT AGAINST SARS-COV-2: IN VITRO STUDY |
AVIN AINUR FITRIANINGSIH, DEWI SANTOSANINGSIH, SUSANTHY DJAJALAKSANA, SETYAWATI SOEHARTO KARYONO, ROIHATUL MUTI'AH, MARIA INGE LUSIDA, SUMARNO RETO PRAWIRO |
| 16 |
[GO] |
2023―Dec―20 |
IN SILICO STUDY OF EUCALYPTOL FROM EUCALYPTUS GLOBULUS LABILL. AGAINST ANGIOTENSIN-CONVERTING ENZYME AS AN ANTIHYPERTENSIVE IN COVID-19 COMORBID |
RESMI MUSTARICHIE, NYI MEKAR SAPTARINI, EDWIN PRATAMA, SANDRA MEGANTARA |
| 17 |
[GO] |
2023―Nov―12 |
LONG-TERM COVID-19 EFFECT TO ENDOTHELIAL DAMAGE TROUGH EXTRINSIC APOPTOSIS LED TO CARDIOVASCULAR DISEASE PROGRESSION: AN UPDATE REVIEW |
MATTHEW JUSTYN, TRILIS YULIANTI, GOFARANA WILAR |
| 18 |
[GO] |
2023―Nov―12 |
EVALUATION OF THE POTENTIAL ASSOCIATED FACTORS CONTRIBUTING TO VARIOUS SIDE EFFECTS OF COVID-19 VACCINES IN BANGLADESH |
SAMIHA TAMANNA, RUPALI GHOSH, SAKIB REZA, SOJIBUL ISLAM, NOOR MUHAMMAD KHAN |
| 19 |
[GO] |
2023―Nov―12 |
MOLECULAR DOCKING AND DYNAMIC SIMULATION-BASED SCREENING IDENTIFIES INHIBITORS OF TARGETED SARS-COV-2 3CLPRO AND HUMAN ACE2 |
SARVESH GALGALE, RIDA ZAINAB, PRADEEP KUMAR A., NITHYA M., SUSHA D., SAMEER SHARMA |
| 20 |
[GO] |
2023―Sep―10 |
THE POTENTIAL OF INDONESIAN MARINE NATURAL PRODUCT WITH DUAL TARGETING ACTIVITY THROUGH SARS-COV-2 3CLPRO AND PLPRO: AN IN SILICO STUDIES |
CIKAL FIARSI NAHIR, MASTERIA YUNOVILSA PUTRA, JOKO TRI WIBOWO, VANNAJAN SANGHIRAN LEE, ARRY YANUAR |
| 21 |
[GO] |
2023―Jan―11 |
QUST AL HINDI (SAUSSUREA LAPPA): A NARRATIVE REVIEW OF ITS PHYTOCHEMISTRY AND PHARMACOLOGICAL POTENTIAL AGAINST COVID-19 |
SUKMAWATI S., IDA MUSFIROH, ADRYAN FRISTIOHADY |
| 22 |
[GO] |
2023―Jan―11 |
NICLOSAMIDE: A POTENTIAL TREATMENT OPTION FOR COVID-19 |
SHWETA VIBHUTE, ADITI KASAR, HRISHIKESH MAHALE, MAHESH GAIKWAD, MADHUR KULKARNI |
| 23 |
[GO] |
2023―Jan―11 |
NATURAL PLANT REMEDIES FOR DEPRESSION DURING THE COVID-19 PANDEMIC, UPDATE REVIEW |
GOFARANA WILAR, SRI BETHA PUTRI, BUNGA MUSTIKAWATI KUSMARA, KIVA AGITA |
| 24 |
[GO] |
2023―Jan―11 |
IDENTIFICATION OF POTENTIAL ACTIVITY OF VOLATILE COMPOUNDS DERIVED FROM POGOSTEMON CABLIN BENTH AS ANTIVIRAL OF SARS-COV-2 |
YULANDA ANTONIUS, JEREMI ONGKO, POPY HARTATIE HARDJO |
| 25 |
[GO] |
2022―Nov―20 |
SARS-COV-2 3CL-PROTEASE INHIBITORS AS ANTIVIRAL AGENT AGAINST COVID-19 |
MOHAMED J. SAADH |
| 26 |
[GO] |
2022―Sep―11 |
A BRIEF DESCRIPTION OF COVID-19 PULMONARY VIRAL INFECTION AND REPURPOSING OF DRUGS FOR ITS TREATMENT |
MANISHA PATEL, RUPA MAZUMDER, KAMAL KANT KAUSHIK, ABHIJIT DEBNATH, RAKHI MISHRA, SHUBHAM PAL |
| 27 |
[GO] |
2022―Jul―18 |
IVERMECTIN IN THE TREATMENT OF COVID-19 DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS |
DEWA AYU AGUS SRI LAKSEMI, I. KETUT TUNAS, PUTU EKA WIDYADHARMA, WAYAN GDE ARTAWAN, LUH PUTU RATNA SUNDARI |
| 28 |
[GO] |
2022―Jul―02 |
PRELIMINARY STUDY FOR COVID-19 DRUG DISCOVERY OF 30 PHYTOCHEMICAL COMPOUNDS FROM TETRAGONULA SP. PROPOLIS AS PAK1 INHIBITOR THROUGH MOLECULAR DOCKING |
SAFIRA CANDRA ASIH, MUHAMAD SAHLAN, MOHAMMAD NASIKIN |
| 29 |
[GO] |
2022―Jul―02 |
MOLECULAR DOCKING OF CYMBOPOGON NARDUS (L.) RENDLE COMPOUNDS AS A PROTEASE INHIBITOR OF SARS-COV-2 |
FAJRI RIFALDI, ESTI MUMPUNI, SHIRLY KUMALA, NOVI YANTIH, DESI NADYA AULENA, SAFIRA NAFISA |
| 30 |
[GO] |
2022―May―11 |
OMICRON SARS-CoV-2 VARIANT, B.1.1.529: SEVERITY, TRANSMISSION, MUTATION, AND EFFICACY OF CURRENT VACCINES |
MOHAMED J. SAADH |
| 31 |
[GO] |
2022―Apr―03 |
TREATMENT PROFILE AND SURVIVAL ANALYSIS ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) COVID-19 PATIENTS |
DIANA LAILA RAMATILLAH |
| 32 |
[GO] |
2022―Apr―03 |
EVALUATION OF BMI RELATIONSHIP WITH INCREASED D-DIMER IN COVID-19 PATIENTS AT A JAKARTA PRIVATE HOSPITAL |
MANUEL VESSELALDO, DIANA LAILA RAMATILLAH |
| 33 |
[GO] |
2022―Jan―09 |
MOLECULAR DOCKING AND SCREENING OF DRUGS FOR 6LU7 PROTEASE INHIBITOR AS A POTENTIAL TARGET FOR COVID-19 |
MANOJ GADEWAR, BHARAT LAL |
| 34 |
[GO] |
2022―Jan―09 |
LONG-TERM IMMUNOLOGICAL CONSEQUENCES OF COVID-19 ON HEALTH |
HARSHADA KADAM, GAURI KAPHARE, RUPALI AVHAD, PRAJWAL AHER, NIKHIL GADE, MANOJ BAJAIT, et al. (+2) SWATI TALELE, ANIL JADHAV |
| 35 |
[GO] |
2022―Jan―09 |
LESSONS AND NEW PERSPECTIVES: IS CONVALESCENT PLASMA THERAPY EFFECTIVE ON COVID-19 PATIENTS? |
HERNITA TAURUSTYA, SRI YUNITA, YSRAFIL YSRAFIL, NUKE PRATIWI, ANINDITA RAHMATIAH |
| 36 |
[GO] |
2022―Jan―09 |
HIGH-THROUGHPUT SCREENING AND DYNAMIC STUDIES OF SELECTED COMPOUNDS AGAINST SARS-COV-2 |
RATUL BHOWMIK, RANAJIT NATH, SAMEER SHARMA, RATNA ROY, RIYA BISWAS |
| 37 |
[GO] |
2021―Dec―14 |
DEVELOPMENT AND PSYCHOMETRIC TESTING OF KNOWLEDGE, ATTITUDE, AND PRACTICE ON COVID-19 OUTBREAK QUESTIONNAIRE (KAPCovQ) FOR GENERAL COMMUNITY |
HIDAYAH KARUNIAWATI, TRI YULIANTI, LISTIANA MASYITA DEWI, WIDYANA ATMA MAULIDA, NUR LAELA, SEKAR MELATI KUSUMANING AYU |
| 38 |
[GO] |
2021―Dec―14 |
COMPARES mRNA AND ADENOVIRUS-BASED SARS-CoV-2 VACCINES |
HISA FAADHILAH, KARINA O. WISEVA, FRIDA WIDYASTUTI, NASRUL WATHONI |
| 39 |
[GO] |
2021―Sep―12 |
A REVIEW ON COVID-19 PANDEMIC A GLOBAL THREAT-CURRENT STATUS AND CHALLENGES AND PREVENTIVE STRATEGIES |
SUNITHA SUKUMARAN, S. SATHIANARAYANAN |
| 40 |
[GO] |
2021―Sep―12 |
IMPACT OF COVID-19 ON MULTIPLE BODY ORGAN FAILURE: A REVIEW |
AYA YASEEN MAHMOOD ALABDALI, SASIKALA CHINNAPPAN, BASMA M. ABD RAZIK, MOGANA R., SHAIK IBRAHIM KHALIVULLA, RAHMAN H., LAITH H. SAMEIN |
| 41 |
[GO] |
2021―Sep―12 |
SUPPORTIVE THERAPY: AN OPTION TO ENHANCE HOST IMMUNITY AGAINST COVID-19 |
AMRUTHA V. U., ARYA G. K., ARYA M., VANI VIJAY, AKSHAYA KRISHNA, ABHINANDH B., et al. (+2) ANAND CHANDRAN, SREEJA C. NAIR |
| 42 |
[GO] |
2021―Sep―12 |
A RIPPLE EFFECT OF COVID-19 PANDEMIC ON SHORTAGE OF MEDICINAL PRODUCTS AND ITS IMPACT ON PATIENT CARE |
BIPLAB KUMAR DEY, EFFICIENCY MYRSING, RUHUL AMIN, FARUK ALAM, MIZANUR RAHMAN, PAL GOGOI, TAHMINA AFROZ |
| 43 |
[GO] |
2021―Sep―12 |
EVOLUTIONARY RELATIONSHIP AND REPURPOSING OF SARS INHIBITORS AGAINST SURFACE GLYCOPROTEIN OF SARS-COV-2 |
PRIYANKA RAJBHAR, DIKSHANT SINGH, RUKHSAR FATIMA, RUCHI YADAV |
| 44 |
[GO] |
2021―Sep―12 |
NANOPARTICLE AS THE STRATEGY FOR THE DEVELOPMENT OF SARS-COV-2 ANTIVIRAL DRUGS |
SRI HARTATI YULIANI |
| 45 |
[GO] |
2021―Jul―14 |
THE EFFICACY OF COVID-19 VACCINE AND THE CHALLENGE IN IMPLEMENTING MASS VACCINATION IN INDONESIA |
I. KETUT TUNAS, DEWA AYU AGUS SRI LAKSEMI, I. PUTU EKA WIDYADHARMA, LUH PUTU RATNA SUNDARI |
| 46 |
[GO] |
2021―May―13 |
STATE-OF-THE-ART NANOTECHNOLOGY BASED DRUG DELIVERY STRATEGIES TO COMBAT COVID-19 |
SHARON K. JOSEPH, ARYA M. A., SACHIN THOMAS, SREEJA C. NAIR |
| 47 |
[GO] |
2021―May―13 |
PHARMACOVIGILANCE IN THE ERA OF COVID-19: A CONCISE REVIEW OF THE CURRENT SCENARIO, IMPLICATIONS, AND CHALLENGES |
SIDDHARTHA DUTTA, SNEHA AMBWANI, GOVIND MISHRA, HINA LAL, KISHNA RAM, TARUN KUMAR |
| 48 |
[GO] |
2021―May―13 |
RISE AND FALL IN SARS-COV-2 GLOBAL PANDEMIC STRAIN RATE-AN OVERVIEW |
ABDULLAH ANWA, VISHAL SINGH CHANDEL, SATYENDRA PRATAP SINGH, SATYA PRAKASH SINGH, NEDA ANWAR |
| 49 |
[GO] |
2021―Mar―15 |
TREATMENT MODALITIES OF THE COVID-19 PANDEMIC THROUGH REPURPOSED DRUGS AND STATUS OF VACCINES |
MD SADIQUE HUSSSAIN, PARUL PAMMA, BABY KUMARI |
| 50 |
[GO] |
2021―Mar―15 |
MOLECULAR DOCKING STUDY BETWEEN 3 THAI MEDICINAL PLANTS COMPOUNDS AND COVID-19 THERAPEUTIC PROTEIN TARGETS: SARS-COV-2 MAIN PROTEASE, ACE-2, AND PAK-1 |
SAFIRA CANDRA ASIH, RAFIDHA IRDIANI, MUHAMAD SAHLAN, MOHAMMAD NASIKIN |
| 51 |
[GO] |
2021―Mar―15 |
IDENTIFYING PROPOLIS COMPOUNDS POTENTIAL TO BE COVID-19 THERAPIES BY TARGETING SARS-COV-2 MAIN PROTEASE |
LIA KUSUMA DEWI, MUHAMAD SAHLAN, DIAH KARTIKA PRATAMI, ALI AGUS, ARDO SABIR |
| 52 |
[GO] |
2021―Mar―15 |
WILL THE TRADITIONAL MEDICINE UN-PAUSE THE WORLD AND DECIDE THE FATE OF COVID-19? |
JANANI S. K., DHANABAL S. P., SURESHKUMAR R., CHENMALA KARTHIKA, SAI SURYA NIKITHA UPADHYAYULA |
| 53 |
[GO] |
2021―Jan―10 |
DETAILED VIEW ON REPURPOSED DRUGS, TRACKING OF VACCINES,AND BRIEF VIEW ON PROPHYLACTIC NANOMEDICINES AS AN ALTERNATIVE APPROACH AND PATIENT CARE FOR COVID-19 |
KRISHNANJANA S. NAIR, SHIVALI KAMATH, ARYA RAJAN, SACHIN THOMAS, ASWIN D., SUBIN MARY ZACHARIAH |
| 54 |
[GO] |
2021―Jan―10 |
PHARMACY PROFESSIONS IN INDIADURING COVID-19 PANDEMIC: PRESENT STATUS, FUTURE CHALLENGES AND A WAY FORWARD |
VIGNESH M., GANESH G. N. K. |
| 55 |
[GO] |
2020―Sep―12 |
PROSPECT OF STEM CELL THERAPY TO AVOID CYTOKINE STORM IN SEVERE COVID-19 |
J. A. PAWITAN |
| 56 |
[GO] |
2020―Sep―12 |
COVID-19: EPIDEMIOLOGY, PATHOGENICITY AND GLOBAL UPDATES |
MANJINDER SINGH, MANJU NAGPAL, VARINDER SINGH, AMEYA SHARMA, GITIKA ARORA DHINGRA, PARAMJOT MAMAN, VIVEK PURI |
